Hepatitis C treatment: latest news

Hepatitis C treatment resources

  • Hepatitis C treatment

    Effective treatments are available for hepatitis C. This field is evolving rapidly and standards of care are changing. The newest drugs can cure most people with hepatitis...

    From: Booklets

    Information level Level 2
  • Medications for hepatitis C

    The old standard of care for hepatitis C treatment for all HCV genotypes was pegylated interferon and ribavirin. Interferon works by stimulating immune system activity against HCV. There...

    From: Booklets

    Information level Level 2
  • Hepatitis C treatment for people with co-infection

    Current guidelines recommend that you start hepatitis C treatment if you have HIV and HCV co-infection with moderate or worse liver fibrosis (stage F2 to F4) and...

    From: Booklets

    Information level Level 2
  • Hepatitis C

    Hepatitis C virus (HCV) is chiefly transmitted by blood-to-blood contact. When the blood of a person with hepatitis C enters the bloodstream of another person,...

    From: Factsheets

    Information level Level 2
  • Hepatitis C

    Hepatitis C is a serious infection caused by a virus.It damages the liver, which performs essential functions in the body.Some people have hepatitis C for...

    From: The basics

    Information level Level 1
  • Hepatitis C treatment

    Deciding on the best time to take treatment for hepatitis C is not straightforward.It’s important to get support and advice to help you with this...

    From: The basics

    Information level Level 1
  • Hepatitis C virus treatment

    The current preferred treatment regimen for HCV infection is a combination of peginterferon alfa (given by injection) plus ribavirin (given orally). Interferons are human proteins that...

    From: HIV treatments directory

    Information level Level 4

Hepatitis C treatment features

Hepatitis C treatment in your own words

Hepatitis C treatment news from aidsmap

More news

Hepatitis C treatment news selected from other sources

  • First Canadian Study Demonstrates Potential to Remove Patients from Active Liver Transplant List After Curing Hepatitis C

    Researchers with the Multi-Organ Transplant Program at London Health Sciences Centre and the Lawson Health Research Institute have been able to remove one-third (33 per cent) of patients from the active liver transplant waiting list by "curing" them of their Hepatitis C disease.

    22 hours ago | Lawson Health Research Institute press release
  • 'Aggressive' pricing helps Merck steal hep C share with newcomer Zepatier

    Merck & Co. has yet to report first-quarter earnings, so industry watchers still don’t know exactly how much market share the company’s new hep C combo treatment, Zepatier, has scored since winning approval in late January. But so far, comments from its competitors suggest it’s doing pretty well for itself.

    03 May 2016 | Fierce Pharma
  • New York Insurers to Change Coverage of Hepatitis C Drugs

    Seven health-insurance companies in New York will change their criteria for covering costly drugs that cure chronic hepatitis C under the terms of agreements with the office of State Attorney General Eric Schneiderman.

    26 April 2016 | Wall Street Journal
  • AIDS expert to head $5-million research efforts on hepatitis C

    Health Minister Terry Lake on Thursday announced a $5-million study that will look at how to reduce the spread of hepatitis C among intravenous drug users, sex workers and men who have sex with men. It will concentrate on people who have already taken medication that clears them of the hepatitis C virus, but who could be reinfected if they have blood-to-blood contact with another person. They will be encouraged to prevent that by using condoms, not sharing needles and taking part in support programs through Vancouver Coastal Health, one of the five organizations involved in the program.

    22 April 2016 | Vancouver Sun
  • Hepatitis C: no more treatment rationing; universal access to generic medicines everywhere!

    People with hepatitis C virus (HCV) and their allies from Spain and around the world have gathered at the International Liver Congress to protest the outrageous price of life-saving HCV medicines. They are pushing for generic competition to bring down the price of HCV treatment and ensure universal access.

    18 April 2016 | Treatment Action Group
  • Innovative new programme set to treat 10,000 patients co-infected with hepatitis C and HIV in Africa and Asia

    The World Hepatitis Alliance welcomes the announcement of a new programme initiated by the Clinton Health Access Initiative, Inc. (CHAI) and AmeriCares that aims to treat 10,000 co-infected HIV and hepatitis C patients in Africa and Asia with new hepatitis C treatment Daklinza (daclatasvir).

    14 April 2016 | World Hepatitis Alliance
  • Community-based treatment providers can help ease pressure on specialists in battle against hep C

    A new study, presented today, demonstrates treatment for hepatitis C can be provided safely and effectively within a community-based and non-specialist setting. This illustrates the potential for alternative providers to ease pressure on currently overburdened specialists. The study, sponsored by the National Institutes of Health, was presented at The International Liver Congress™ 2016 in Barcelona, Spain.

    13 April 2016 | EASL press release
  • Differing perspectives on antiviral treatment efficacy in patients co-infected with HIV and HCV

    Two separate studies presented today at The International Liver Congress 2016 in Barcelona, Spain have offered alternative conclusions regarding the efficacy of direct-acting antivirals (DAAs) among patients co-infected with HIV and hepatitis C virus (HCV).

    13 April 2016 | EASL press release
  • New report: Hepatitis B and C could be eliminated as public health problems in US

    It is possible to end the transmission of hepatitis B and C and prevent further sickness and deaths from the diseases, but time, considerable resources, and attention to various barriers will be required, says a new report from the National Academies of Sciences, Engineering, and Medicine.

    12 April 2016 | Eurekalert Inf Dis
  • No waiting lists for Hepatitis C treatment by August: Egypt's health minister

    Waiting lists for Hepatitis C treatment will end by August thanks to donations collected by the Ministry of Religious Endowments, according to Egypt's health minister.

    01 April 2016 | Ahram Online
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.